 |
0 Products |  |
169 Diseases | | 0 Products |
|
0 Trials |  |
60 News |  |
- | human interleukin-2 inhalation / Immunservice
Clinical, P1 data, Journal: Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia. (Pubmed Central) - Mar 7, 2018
The trial demonstrated the safety and feasibility of adoptive cell therapy with "off-the-shelf" aNK cells in patients with refractory/relapsed AML. These data provide the foundation for future combination immunotherapy trials and for the optimization of aNK cell based therapies in patients with AML.